Background: The NS1 protein of avian influenza virus (AIV) is an important virulent factor of AIV. It has been shown to counteract host type I interferon response, to mediate host cell apoptosis, and to regulate the process of protein synthesis. The identification of AIV epitopes on NS1 protein is important for understanding influenza virus pathogenesis. Results: In this paper, we describe the generation, identification, and epitope mapping of a NS1 protein-specific monoclonal antibody (MAb) D9. First, to induce the production of MAbs, BALB/c mice were immunized with a purified recombinant NS1 expressed in E. coli. The spleen cells from the immunized mice were fused with myeloma cells SP2/0, and through screening via indirect ELISAs, a MAb,...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Antibodies (Ab) to neuraminidase (NA) play a role in limiting influenza infection and might help red...
Background: The development of new therapeutic targets and strategies to control highly pathogenic a...
Avian Influenza (AI) caused by the H9N2 subtype of the avian influenza virus (AIV) poses a serious t...
This is an open access article distributed under the Creative Commons Attribution License, which per...
H9N2 subtype of avian influenza virus (AIV) is primarily a bird virus, which is widespread in clinic...
The inflammasome is a molecular platform that stimulates the activation of caspase-1 and the process...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
A complete map of potential pathogenicity markers of avian influenza virus subtype H5 predicted from...
The recent emergence of a novel H7N9 influenza A virus (IAV) causing severe human infections in Chin...
<p>H5N1 avian influenza virus has caused widespread infection in poultry and wild birds, and h...
Avian influenza virus (AIV) infection is a continuing threat to both humans and poultry. Influenza v...
Influenza A virus causes significant morbidity and excessive mortality around the world every year a...
article en Open AccessInternational audienceBackground: Non-structural protein NS1 of influenza A vi...
The influenza A virus nucleoprotein (NP) is an attractive target for avian flu vaccine development b...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Antibodies (Ab) to neuraminidase (NA) play a role in limiting influenza infection and might help red...
Background: The development of new therapeutic targets and strategies to control highly pathogenic a...
Avian Influenza (AI) caused by the H9N2 subtype of the avian influenza virus (AIV) poses a serious t...
This is an open access article distributed under the Creative Commons Attribution License, which per...
H9N2 subtype of avian influenza virus (AIV) is primarily a bird virus, which is widespread in clinic...
The inflammasome is a molecular platform that stimulates the activation of caspase-1 and the process...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
A complete map of potential pathogenicity markers of avian influenza virus subtype H5 predicted from...
The recent emergence of a novel H7N9 influenza A virus (IAV) causing severe human infections in Chin...
<p>H5N1 avian influenza virus has caused widespread infection in poultry and wild birds, and h...
Avian influenza virus (AIV) infection is a continuing threat to both humans and poultry. Influenza v...
Influenza A virus causes significant morbidity and excessive mortality around the world every year a...
article en Open AccessInternational audienceBackground: Non-structural protein NS1 of influenza A vi...
The influenza A virus nucleoprotein (NP) is an attractive target for avian flu vaccine development b...
permits unrestricted use, distribution, and reproduction in any medium, provided the original work i...
Antibodies (Ab) to neuraminidase (NA) play a role in limiting influenza infection and might help red...
Background: The development of new therapeutic targets and strategies to control highly pathogenic a...